4
Views
34
CrossRef citations to date
0
Altmetric
Reports

Chemopreventive effects of β‐carotene and 13‐cis‐retinoic acid on salivary gland tumors

, , &
Pages 4-12 | Published online: 04 Aug 2009
 

Abstract

The chemopreventive effects of β‐carotene and 13‐cis‐retinoic acid (RA) on chemically induced salivary gland tumors were studied in rats. Young male Sprague‐Dawley rats were injected in one of the submandibular salivary glands with 1 mg of dimethylbenzanthracene (DMBA) dissolved in olive oil. The contralateral gland was injected with the vehicle alone. Rats were divided into four groups and were fed ad libitum a semisynthetic diet supplemented with 0 or 100 mg β‐carotene/kg diet, or 20 or 100 mg RA/kg diet. Rats were killed at 22 weeks after the DMBA treatment, and tumors were examined histologically. Tumors were generally found to be squamous cell carcinomas or poorly differentiated neoplasms resembling squamous cell carcinomas. The tumor incidence was slightly lower in rats fed the diet supplemented with β‐carotene. RA had no appreciable effect on tumor incidence. A high activity of γ‐glutamyl transpeptidase was histochemically demonstrated in the tumors. There were some mortalities in the β‐carotene and RA supplemented groups, especially in the group fed high levels of RA. This mortality appeared to be related to vitamin K becoming somewhat limited.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.